首页> 外文期刊>Expert opinion on therapeutic targets >The role of vasoactive intestinal peptide in neuroprotection: Professor Illana Gozes is interviewed by Emma Quigley.
【24h】

The role of vasoactive intestinal peptide in neuroprotection: Professor Illana Gozes is interviewed by Emma Quigley.

机译:血管活性肠肽在神经保护中的作用:艾玛娜·古兹(Illana Gozes)教授接受了艾玛·奎格利(Emma Quigley)的采访。

获取原文
获取原文并翻译 | 示例
       

摘要

Professor Illana Gozes was interviewed by Emma Quigley (Senior Editor, Expert Opinion) on 17(th) April 2007. Professor Illana Gozes BSc, PhD holds the titles of Professor of Clinical Biochemistry; The Lily and Avraham Gildor Chair for the Investigation of Growth Factors; Director of Adams Super Center for Brain Studies and Levi-Edersheim-Gitter fMRI Institute; Head of the Dr Diana and Zelman Elton (Elbaum) Laboratory for Molecular Neuroendocrinology, Tel Aviv University and Chief Scientific Officer, Allon Therapeutics, Inc., Vancouver BC, Canada. Professor Gozes has served as a member (or chair) of several faculty, university or national and international committees and she currently serves on the Board of Directors of Allon Therapeutics, the Scientific Review Board of the ISOA, and is the Editor-in-Chief of the Journal of Molecular Neuroscience. Professor Gozes has received a number of scientific awards for her work including the Landau Award for an excellent PhD dissertation, the Juludan Prize and the Teva Founders Prize for exceptional scientific studies that may lead to biotechnology developments as well as the Bergmann Prize and the Neufeld award for outstanding/leading US-Israel BSF grant proposals, and has published extensively in the fields of molecular neuroscience and neuroprotection (> 200 scientific manuscripts). She is co-inventor of > 15 patents and applications, including the composition of matter patent on AL-108 and AL-208, Allon's lead compounds. Professor Gozes received a BSc from Tel Aviv University, a PhD from The Weizmann Institute of Science and was a Weizmann Postdoctoral Fellow at Massachusetts Institute of Technology, Research Associate/Visiting Scientist at the Salk Institute and the Scripps Clinic and Research Foundation, a Senior Scientist/Associate Professor at the Weizmann Institute and a Fogarty-Scholar-in-Residence at the National Institutes of Health (USA). Professor Gozes directs a very active research laboratory at Tel Aviv University and is mentoring and has mentored directly approximately 50 graduate students toward their MSc or PhD degrees.
机译:Illana Gozes教授于2007年4月17日接受了Emma Quigley(专家意见的高级编辑)的采访。IllanaGozes教授理学学士学位为临床生物化学教授; Lily和Avraham Gildor研究生长因子的主席;亚当斯大脑研究超级中心和Levi-Edersheim-Gitter fMRI研究所所长;特拉维夫大学戴安娜博士和泽尔曼·埃尔顿(Elbaum)分子神经内分泌实验室负责人,加拿大卑诗省温哥华Allon Therapeutics,Inc.首席科学官。 Gozes教授曾担任过多个学院,大学或国家和国际委员会的成员(或主席),目前是Allon Therapeutics董事会,ISOA科学审查委员会的成员,并且是主编。分子神经科学杂志。 Gozes教授的工作获得了许多科学奖,包括杰出博士学位论文Landau奖,Julidan奖和Teva Founders奖(因其可能导致生物技术发展的杰出科学研究)以及Bergmann奖和Neufeld奖。美国杰出的/领先的美国-以色列BSF资助计划,并已在分子神经科学和神经保护领域广泛发表(> 200篇科学手稿)。她是> 15项专利和申请的共同发明人,其中包括Allon的先导化合物AL-108和AL-208的物质专利组成。 Gozes教授获得了特拉维夫大学的理学学士学位,魏兹曼科学研究所的博士学位,并且是麻省理工学院的魏兹曼博士后研究员,萨尔克研究所研究助理/客座科学家以及斯克里普斯诊所和研究基金会的资深科学家/ Weizmann研究所副教授,美国国立卫生研究院(National Institutes of Health)驻地的Fogarty-Scholar-in-Residence。 Gozes教授领导着特拉维夫大学一个非常活跃的研究实验室,并进行了指导,并已经直接指导了约50名研究生获得其理学硕士或博士学位。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号